Korea Investment CORP Takes $34.58 Million Position in Humana Inc. $HUM

Key Points

• Korea Investment CORP purchased 87,053 Humana shares worth approximately $34.58 million, giving it a 0.07% stake. Institutional investors collectively own 92.38% of HUM.
• Analyst sentiment is mixed, with 14 Buy, 15 Hold, and one Sell rating; the consensus rating is Hold, with an average price target of $395.22.
• Humana reported quarterly earnings of $7.61 per share, exceeding estimates of $7.27, while revenue rose 26.2% year over year to $40.89 billion. The stock opened at $379.22, down 0.4%.

Korea Investment CORP purchased a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 87,053 shares of the insurance provider's stock, valued at approximately $34,579,000. Korea Investment CORP owned 0.07% of Humana at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HUM. BlackRock Inc. purchased a new position in Humana during the 2nd quarter worth $4,138,160,000. Pzena Investment Management LLC purchased a new stake in shares of Humana in the second quarter valued at about $1,749,014,000. Capital International Investors increased its stake in shares of Humana by 113.9% during the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider's stock worth $1,490,239,000 after acquiring an additional 3,097,571 shares during the period. Norges Bank acquired a new position in shares of Humana during the fourth quarter worth about $456,632,000. Finally, Wellington Management Group LLP raised its holdings in Humana by 4,481.7% during the fourth quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider's stock worth $306,460,000 after purchasing an additional 1,170,387 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HUM has been the subject of a number of recent analyst reports. Lake Street Capital assumed coverage on shares of Humana in a research report on Thursday, July 30th. They issued a "buy" rating for the company. TD Cowen increased their target price on Humana from $350.00 to $370.00 and gave the stock a "hold" rating in a research note on Friday, July 31st. Zacks Research cut Humana from a "strong-buy" rating to a "hold" rating in a report on Tuesday, August 11th. Jefferies Financial Group upgraded Humana from a "buy" rating to a "buy" rating in a research note on Wednesday, May 20th. Finally, Sanford C. Bernstein reaffirmed an "outperform" rating and set a $425.00 price objective on shares of Humana in a report on Wednesday, June 3rd. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $395.22.

Humana Stock Down 0.4%

HUM stock opened at $379.22 on Friday. The company has a market cap of $45.54 billion, a P/E ratio of 35.88, a P/E/G ratio of 2.17 and a beta of 0.72. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88. The company's 50-day moving average price is $383.38 and its 200 day moving average price is $281.59. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same period in the prior year, the business posted $6.27 earnings per share. The firm's revenue for the quarter was up 26.2% compared to the same quarter last year. On average, research analysts expect that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

About Humana

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source